Expression of PHGDH, the rate-limiting enzyme in serine biosynthesis, was characterized in a triple-blind fashion using immunohistochemistry on a tumor microarray of 392 tumor samples from 260 patients with osteosarcoma (Figure 1D; patient characteristics are presented in Table S1). Here, PHGDH is linked to osteosarcoma.